Kenvue Inc. Common Stock (KVUE)

In a pivotal moment for the consumer health landscape, Kenvue (NYSE: KVUE) has reported a robust set of fourth-quarter results for 2025, signaling a successful turnaround and strategic resilience just months after the announcement of its blockbuster merger. On February 17, 2026, the company revealed that its Q4 net sales

This Dividend King has an appealing 4.7% dividend yield.

On Feb. 18, 2026, investors weighed Kenvue's earnings momentum against looming merger costs and related risks.

As of February 6, 2026, the global financial landscape is still reverberating from a historic tectonic shift that occurred in the final months of last year. In the fourth quarter of 2025, the M&A market witnessed an unprecedented "mega-deal" frenzy, with 22 global transactions valued at over $10 billion

Chevron and Kimberly Clark check all the boxes for generating reliable passive income from dividend stocks.

Consumer staples stocks being out of favor is an impeccable buying opportunity for value investors.

These market giants make great long-term investments.

Near a 12-year low, Kimberly-Clark may be one of the best deep value stocks for income investors to buy in 2026.

In a move that signals a seismic shift within the consumer staples landscape, Kimberly-Clark (NYSE:KMB) is on the precipice of finalizing its $48.7 billion acquisition of Kenvue (NYSE:KVUE). This colossal deal, if ratified by shareholders tomorrow, January 29, 2026, would create a diversified powerhouse with a formidable